Skip to main content

Lynparza Side Effects

Generic name: olaparib

Medically reviewed by Drugs.com. Last updated on Nov 26, 2023.

Note: This document contains side effect information about olaparib. Some dosage forms listed on this page may not apply to the brand name Lynparza.

Applies to olaparib: oral tablet.

Serious side effects of Lynparza

Along with its needed effects, olaparib (the active ingredient contained in Lynparza) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking olaparib:

More common

Incidence not known

Other side effects of Lynparza

Some side effects of olaparib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to olaparib: oral capsule, oral tablet.

General

The most common adverse reactions reported in 10% or greater patients were nausea (60%), fatigue (55%), anemia (36%), vomiting (32%), diarrhea (24%), decreased appetite (22%), headache (16%), dysgeusia (15%), cough (15%), neutropenia (14%), dyspnea (14%), dizziness (12%), dyspepsia (12%), leukopenia (11%), and thrombocytopenia (10%).

Cardiovascular

Very common (10% or more): Hypertension (19%)

Common (1% to 10%): Venous thrombosis[Ref]

Dermatologic

Very common (10% or more): Dermatitis/rash (up to 15%)

Rare (0.01% to 0.1%): Angioedema, erythema nodosum[Ref]

Gastrointestinal

Very common (10% or more): Nausea (up to 77%), abdominal pain/discomfort (up to 45%), vomiting (up to 40%), diarrhea (up to 37%), dyspepsia (up to 20%), constipation (28%), stomatitis (up to 11%)[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection (13%)[Ref]

Hematologic

Very common (10% or more): Decreased hemoglobin (up to 98%), elevated mean corpuscular volume (up to 89%), decreased lymphocytes (up to 77%), anemia (up to 46%), decreased absolute neutrophil count (up to 51%), decreased platelets (up to 56%), neutropenia (27%), leukopenia (25%), thrombocytopenia (14%)[Ref]

The term neutropenia includes febrile neutropenia, granulocyte count decreased, granulocytopenia, neutropenia, neutropenic infection, neutropenic sepsis, and neutrophil count decreased.[Ref]

Immunologic

Uncommon (0.1% to 1%): Hypersensitivity

Metabolic

Very common (10% or more): Decreased appetite (up to 30%), hypomagnesemia (14%)[Ref]

Musculoskeletal

Very common (10% or more): Arthralgia/ myalgia, back pain (up to 19%)[Ref]

Nervous system

Very common (10% or more): Headache (up to 26%), dysgeusia (up to 27%), dizziness (up to 20%)[Ref]

Oncologic

Uncommon (0.1% to 1%): Myelodysplastic syndrome/Acute Myeloid Leukemia[Ref]

Other

Very common (10% or more): Fatigue/malaise/asthenia/lethargy (up to 67%)

Common (1% to 10%): Pyrexia[Ref]

Renal

Very common (10% or more): Increased creatinine (up to 30%)[Ref]

Respiratory

Very common (10% or more): Nasopharyngitis/pharyngitis/upper respiratory infection (up to 43%), cough (up to 15%), dyspnea (15%)

Common (1% to 10%): Pulmonary embolism

Uncommon (0.1% to 1%): Pneumonitis

Frequency not reported: Rhinitis[Ref]

Frequently asked questions

References

1. Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals. 2014.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.